Annual SG&A
$27.65 M
-$2.48 M-8.23%
31 December 2023
Summary:
Cara Therapeutics annual selling, general & administrative expenses is currently $27.65 million, with the most recent change of -$2.48 million (-8.23%) on 31 December 2023. During the last 3 years, it has risen by +$5.90 million (+27.13%). CARA annual SG&A is now -8.23% below its all-time high of $30.13 million, reached on 31 December 2022.CARA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.40 M
+$33.00 K+0.52%
30 September 2024
Summary:
Cara Therapeutics quarterly selling, general & administrative expenses is currently $6.40 million, with the most recent change of +$33.00 thousand (+0.52%) on 30 September 2024. Over the past year, it has dropped by -$322.00 thousand (-4.79%). CARA quarterly SG&A is now -44.23% below its all-time high of $11.48 million, reached on 31 December 2021.CARA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.88 B
-$95.53 M-3.43%
30 September 2024
Summary:
Cara Therapeutics TTM selling, general & administrative expenses is currently -$2.88 billion, with the most recent change of -$95.53 million (-3.43%) on 30 September 2024. Over the past year, it has dropped by -$2.91 billion (-10587.26%). CARA TTM SG&A is now -4755.81% below its all-time high of $35.21 million, reached on 30 September 2022.CARA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.2% | -4.8% | -10000.0% |
| 3 y3 years | +27.1% | +9.4% | -10000.0% |
| 5 y5 years | +81.5% | +52.3% | -10000.0% |
CARA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.2% | +27.1% | -44.2% | +9.4% | -69.5% | at low |
| 5 y | 5 years | -8.2% | +81.5% | -44.2% | +52.3% | -118.1% | at low |
| alltime | all time | -8.2% | +1048.7% | -44.2% | +1589.2% | -4755.8% | at low |
Cara Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.40 M(+0.5%) | $26.11 M(-1.2%) |
| June 2024 | - | $6.37 M(-6.1%) | $26.43 M(-4.2%) |
| Mar 2024 | - | $6.79 M(+3.6%) | $27.57 M(-0.3%) |
| Dec 2023 | $27.65 M(-8.2%) | $6.55 M(-2.6%) | $27.65 M(+0.6%) |
| Sept 2023 | - | $6.72 M(-10.5%) | $27.50 M(-0.6%) |
| June 2023 | - | $7.51 M(+9.5%) | $27.65 M(-0.1%) |
| Mar 2023 | - | $6.86 M(+7.3%) | $27.68 M(-8.1%) |
| Dec 2022 | $30.13 M(+2.9%) | $6.40 M(-7.0%) | $30.13 M(-14.4%) |
| Sept 2022 | - | $6.88 M(-8.7%) | $35.21 M(+3.0%) |
| June 2022 | - | $7.54 M(-19.1%) | $34.18 M(+5.9%) |
| Mar 2022 | - | $9.31 M(-18.9%) | $32.27 M(+10.2%) |
| Dec 2021 | $29.29 M(+34.6%) | $11.48 M(+96.2%) | $29.29 M(+19.9%) |
| Sept 2021 | - | $5.85 M(+4.1%) | $24.43 M(+2.8%) |
| June 2021 | - | $5.62 M(-11.3%) | $23.78 M(+1.0%) |
| Mar 2021 | - | $6.33 M(-4.4%) | $23.55 M(+8.3%) |
| Dec 2020 | $21.75 M(+23.2%) | $6.63 M(+27.6%) | $21.75 M(+10.3%) |
| Sept 2020 | - | $5.20 M(-3.6%) | $19.72 M(+5.3%) |
| June 2020 | - | $5.39 M(+18.8%) | $18.73 M(+2.3%) |
| Mar 2020 | - | $4.54 M(-1.3%) | $18.31 M(+3.7%) |
| Dec 2019 | $17.66 M(+15.9%) | $4.60 M(+9.3%) | $17.66 M(-0.5%) |
| Sept 2019 | - | $4.20 M(-15.4%) | $17.75 M(+6.0%) |
| June 2019 | - | $4.97 M(+27.9%) | $16.75 M(+8.5%) |
| Mar 2019 | - | $3.89 M(-17.1%) | $15.45 M(+1.4%) |
| Dec 2018 | $15.24 M | $4.69 M(+46.3%) | $15.24 M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $3.21 M(-12.5%) | $13.52 M(-4.1%) |
| June 2018 | - | $3.67 M(-0.3%) | $14.10 M(+7.7%) |
| Mar 2018 | - | $3.68 M(+23.6%) | $13.09 M(+11.0%) |
| Dec 2017 | $11.79 M(+37.0%) | $2.98 M(-21.4%) | $11.79 M(+8.8%) |
| Sept 2017 | - | $3.79 M(+42.7%) | $10.84 M(+18.7%) |
| June 2017 | - | $2.65 M(+11.4%) | $9.13 M(+2.8%) |
| Mar 2017 | - | $2.38 M(+17.9%) | $8.89 M(+3.3%) |
| Dec 2016 | $8.61 M(+16.7%) | $2.02 M(-3.0%) | $8.61 M(-0.2%) |
| Sept 2016 | - | $2.08 M(-13.5%) | $8.62 M(+3.7%) |
| June 2016 | - | $2.40 M(+14.5%) | $8.32 M(+7.4%) |
| Mar 2016 | - | $2.10 M(+3.1%) | $7.75 M(+5.0%) |
| Dec 2015 | $7.38 M(+26.8%) | $2.04 M(+14.7%) | $7.38 M(+4.8%) |
| Sept 2015 | - | $1.78 M(-3.1%) | $7.04 M(+5.2%) |
| June 2015 | - | $1.83 M(+5.8%) | $6.70 M(+7.2%) |
| Mar 2015 | - | $1.73 M(+1.8%) | $6.25 M(+7.3%) |
| Dec 2014 | $5.82 M(+84.6%) | $1.70 M(+19.1%) | $5.82 M(+19.9%) |
| Sept 2014 | - | $1.43 M(+3.4%) | $4.86 M(+15.0%) |
| June 2014 | - | $1.38 M(+5.7%) | $4.22 M(+9.0%) |
| Mar 2014 | - | $1.31 M(+77.3%) | $3.87 M(+22.8%) |
| Dec 2013 | $3.15 M(+28.1%) | $737.00 K(-7.3%) | $3.15 M(+12.8%) |
| Sept 2013 | - | $795.00 K(-23.0%) | $2.79 M(+39.8%) |
| June 2013 | - | $1.03 M(+75.7%) | $2.00 M(+106.8%) |
| Mar 2013 | - | $588.00 K(+55.1%) | $967.00 K(+155.1%) |
| Dec 2012 | $2.46 M(+2.3%) | $379.00 K | $379.00 K |
| Dec 2011 | $2.41 M | - | - |
FAQ
- What is Cara Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cara Therapeutics?
- What is Cara Therapeutics annual SG&A year-on-year change?
- What is Cara Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cara Therapeutics?
- What is Cara Therapeutics quarterly SG&A year-on-year change?
- What is Cara Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cara Therapeutics?
- What is Cara Therapeutics TTM SG&A year-on-year change?
What is Cara Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of CARA is $27.65 M
What is the all time high annual SG&A for Cara Therapeutics?
Cara Therapeutics all-time high annual selling, general & administrative expenses is $30.13 M
What is Cara Therapeutics annual SG&A year-on-year change?
Over the past year, CARA annual selling, general & administrative expenses has changed by -$2.48 M (-8.23%)
What is Cara Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of CARA is $6.40 M
What is the all time high quarterly SG&A for Cara Therapeutics?
Cara Therapeutics all-time high quarterly selling, general & administrative expenses is $11.48 M
What is Cara Therapeutics quarterly SG&A year-on-year change?
Over the past year, CARA quarterly selling, general & administrative expenses has changed by -$322.00 K (-4.79%)
What is Cara Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of CARA is -$2.88 B
What is the all time high TTM SG&A for Cara Therapeutics?
Cara Therapeutics all-time high TTM selling, general & administrative expenses is $35.21 M
What is Cara Therapeutics TTM SG&A year-on-year change?
Over the past year, CARA TTM selling, general & administrative expenses has changed by -$2.91 B (-10587.26%)